Authors
Loading...
Case-control study shows accelerated PSA increases years before prostate cancer diagnosis in aging men, indicating PSA rate of change acts as an early disease marker.
H. Ballentine Carter (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: